ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
(Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 2,643.84%251.36K | 168.26%434.55K | -89.77%31.28K | 84.85%-326.37K | 96.52%-4.77K | 101.06%9.16K | 40.30%-636.6K | 469.95%305.83K | -27.84%-2.15M | 87.14%-136.82K |
Net income from continuing operations | 89.15%-54.5K | 26.79%-195.75K | 12.83%-266.71K | 43.08%-1.48M | 2.19%-400.23K | 27.59%-502.33K | 67.56%-267.38K | 47.10%-305.97K | 6.33%-2.59M | -28.82%-409.18K |
Operating gains losses | ---- | ---- | ---- | -198.74%-95.86K | -46.61%-88.97K | 631.93%871 | -727.60%-7.66K | -100.35%-96 | -35.84%-32.09K | -186.98%-60.69K |
Depreciation and amortization | -16.58%53.53K | -10.31%53.97K | -6.21%54.26K | 26.61%242.56K | -9.64%60.37K | 53.43%64.17K | 45.10%60.18K | 39.49%57.85K | -56.87%191.58K | -4.73%66.81K |
Asset impairment expenditure | ---- | ---- | ---- | -34.65%56.14K | ---- | ---- | ---- | ---- | 368.36%85.9K | ---- |
Remuneration paid in stock | -85.26%5.75K | -72.75%16.91K | 28.37%30.71K | 315.47%155.69K | 113.82%30.7K | -47.12%39.01K | -31.86%62.06K | -74.74%23.92K | -93.00%37.47K | -216.67%-222.09K |
Other non cashItems | 24.49%21.54K | 26.84%21.95K | 264.32%21.84K | --88.34K | --47.74K | 865,150.00%17.3K | 1,730,300.00%17.3K | --6K | ---- | ---- |
Change In working capital | -42.32%225.05K | 207.26%537.48K | -63.52%191.19K | 351.81%702.66K | -28.06%289.49K | 236.79%390.14K | -33.32%-501.09K | 57.71%524.13K | -2.32%155.52K | 151.35%402.42K |
-Change in receivables | -110.57%-70.66K | 141.06%167.02K | -113.11%-88.65K | 167.89%999.69K | 108.41%62.09K | 158.00%668.36K | -569.50%-406.79K | 199.23%676.03K | -724.69%-1.47M | 55.70%-738.17K |
-Change in inventory | -52.81%6.41K | 111.72%6.14K | 155.52%8.83K | -133.31%-42.47K | -97.36%12.25K | 105.61%13.58K | 59.19%-52.39K | -145.97%-15.91K | 376.87%127.52K | 279.38%463.4K |
-Change in prepaid assets | --0 | 300.10%10K | --0 | -813.93%-25.59K | -191.74%-5.29K | --1K | ---5K | -90.38%-16.31K | -113.68%-2.8K | 103.91%5.77K |
-Change in payables and accrued expense | 198.81%289.31K | 1,106.04%371.31K | 326.42%271K | -116.36%-245.95K | -69.70%203.45K | -126.40%-292.8K | 88.95%-36.91K | -248.91%-119.69K | 313.72%1.5M | -47.89%671.42K |
-Change in other working capital | ---- | ---16.98K | ---- | --16.98K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 2,643.84%251.36K | 168.26%434.55K | -89.77%31.28K | 84.85%-326.37K | 96.52%-4.77K | 101.06%9.16K | 40.30%-636.6K | 469.95%305.83K | -27.84%-2.15M | 87.14%-136.82K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 281.38%72.51K | 195.31%63.89K | 816.33%10K | 0 | -105.96%-1.38K | -137.01%-39.98K | -162.07%-67.04K |
Net PPE purchase and sale | --0 | --0 | --0 | 281.38%72.51K | 195.31%63.89K | 816.33%10K | --0 | -105.96%-1.38K | -137.01%-39.98K | -162.07%-67.04K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | --0 | 281.38%72.51K | 195.31%63.89K | 816.33%10K | --0 | -105.96%-1.38K | -137.01%-39.98K | -162.07%-67.04K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -50.42%-38.4K | -31.80%-38.33K | -105.59%-38.28K | -38.47%576.92K | 56.99%-52.7K | -106.74%-25.53K | -103.97%-29.08K | 1,540.58%684.23K | -8.01%937.6K | -304.99%-122.52K |
Net issuance payments of debt | -122.24%-23.4K | -65.66%-23.33K | -114.95%-23.28K | -44.47%93.43K | 66.91%-37.7K | -102.78%-10.53K | 69.04%-14.08K | 427.89%155.74K | 199.98%168.24K | -276.54%-113.92K |
Net common stock issuance | --0 | --0 | --0 | -33.93%552K | --0 | --0 | --0 | --552K | -33.69%835.5K | ---1 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
Interest paid (cash flow from financing activities) | 0.00%-15K | 0.00%-15K | -200.00%-15K | ---50K | ---15K | ---15K | ---15K | ---5K | --0 | ---- |
Net other financing activities | ---- | ---- | ---- | 72.02%-18.51K | --0 | ---- | ---- | ---18.51K | 14.26%-66.14K | -860,400.00%-8.6K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -50.42%-38.4K | -31.80%-38.33K | -105.59%-38.28K | -38.47%576.92K | 56.99%-52.7K | -106.74%-25.53K | -103.97%-29.08K | 1,540.58%684.23K | -8.01%937.6K | -304.99%-122.52K |
Net cash flow | ||||||||||
Beginning cash position | 69.45%951.39K | -54.79%555.17K | 135.11%562.17K | -61.91%239.11K | -1.43%554.21K | -21.65%561.45K | 17.08%1.23M | -61.91%239.11K | -57.77%627.78K | -45.81%562.27K |
Current changes in cash | 3,443.71%212.96K | 159.52%396.22K | -100.71%-7K | 182.53%323.06K | 101.97%6.43K | 95.71%-6.37K | -98.27%-665.68K | 134.87%988.68K | 54.17%-391.45K | 19.89%-326.37K |
Effect of exchange rate changes | --0 | --0 | --0 | --0 | -52.52%1.53K | 85.07%-871 | 38.57%-750 | --96 | 159.42%2.78K | 235.30%3.21K |
End cash Position | 110.09%1.16M | 69.45%951.39K | -54.79%555.17K | 135.11%562.17K | 135.11%562.17K | -1.43%554.21K | -21.12%561.45K | 17.08%1.23M | -61.91%239.11K | -61.91%239.11K |
Free cash from | 2,643.84%251.36K | 168.26%434.55K | -89.73%31.28K | 84.26%-349.72K | 86.69%-26.74K | 101.06%9.16K | 40.41%-636.6K | 440.58%304.45K | -31.80%-2.22M | 81.12%-200.82K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.